Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring indicators and optimized antiretroviral management in treatment-naive adults with HIV
ChiCTR-OPC-15006528Phase 4Recruiting
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zidovudine, tenofovir disoproxil fumarate, lamivudine, efavirenz, nevirapine and 1 more in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (3 arms), sponsored by Guangzhou Eighth People's Hospital. Primary endpoints: Proportion of patients with HIV-1 RNA less than 50 copies/mL, Proportion of patients with HIV-1 RNA less than 400 copies/mL and 4 more. Started Sep 2014; status: recruiting.
02
Drugs
zidovudinetenofovir disoproxil fumaratelamivudineefavirenznevirapine
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR-OPC-15006528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006528.